Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-021-04456-5.pdf
Reference5 articles.
1. Taher AT, Musallam KM, Saliba AN, Garziadei G, Cappellini MD (2015) Hemoglobin level and morbidity in non-transfusion-dependent thalassemia. Blood Cells Mol Dis 55:108–109
2. Musallam KM, Cappellini MD, Daar S, Taher AT (2021) Morbidity-free survival and hemoglobin level in non-transfusion-dependent β-thalassemia: a 10-year cohort study. Ann Hematol. https://doi.org/10.1007/s00277-020-04370-2
3. Musallam KM, Rivella S, Taher AT (2021) Management of non-transfusion-dependent beta-thalassemia (NTDT): the next 5 years. Am J Hematol 96:E57–59
4. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115:1886–1892
5. Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, Taher AT (2011) Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia. Haematologica 96:1605–1612
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia;Expert Review of Hematology;2024-07-26
2. Higher hemoglobin is better in thalassemia;Blood;2024-03-07
3. Αlpha-thalassemia: A practical overview;Blood Reviews;2024-03
4. Reduction of extramedullary erythropoiesis and amelioration of anemia in a β‐thalassemia patient treated with thalidomide;American Journal of Hematology;2023-12-26
5. Pyruvate kinase activators: targeting red cell metabolism in thalassemia;Hematology;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3